Diabetes Prevention & Obesity Treatment Act
Requires large-group plans to cover evidence-based obesity and prediabetes prevention/treatment, with optional coverage for FDA‑approved anti-obesity medications (GLP‑1s).
Requires large-group plans to cover evidence-based obesity and prediabetes prevention/treatment, with optional coverage for FDA‑approved anti-obesity medications (GLP‑1s).
WeVote — Public opinion
No community votes yet. Be the first to weigh in from the Vote tab.
Versions